European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

BioNTech AG, Mainz, Germany✝︎

Watch
BioNTech AG

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Create Dossier
BioNTech AG

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

BioNTech AG
Petersberg 91. V V AG

Identification

Ut
District Court of Mainz HRB 41865
Ut
District Court of Bonn HRB 16295
Sirul
Siren 829165844
Siret
Siret 82916584400012
EUID
DET2304V.HRB41865

Address

Mainz, Germany
Bonn, Germany

Corporate purpose

Die Erforschung und Entwicklung von immunologischen Arzneimitteln und Testverfahren zur Diagnostik, Vorbeugung und Therapie von Krebserkrankungen.

History

Marketing & Tech

Network

Loading network

Legal Structure

Last legal representatives Legal form information Premium
Premium
4Member of the Executive Board
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more

Learn more View plans
tax haven banner

Publications

14 Oct 2022
Patent: Selektive, lokale Aktivierung von Mitgliedern der TNF-Rezeptorfamilie durch systemisch inaktive nicht-Antikörper-TNF-Liganden-Fusionsproteine
17 Oct 2019 via MIG GmbH & Co. Fonds 7 KG also 10/10/2018, 07/10/2016, 08/10/2015
Shareholder: MIG GmbH & Co. Fonds 7 KG
Year 2019 in Dpmam
21 trademark filings: BIONTECH, MeCIT, MiCIT, Microkine, MyCIT, Selecore, miCIT …
27 Mar 2019
Patent: Particles Comprising Protamine and RNA in Combination with Endosome Destabilizing Agents
8 Mar 2019
Change of legal form: Europäische Aktiengesellschaft BioNTech SE · Legal form: SE
21 Feb 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017 · Shareholdings (11 companies)
14 Feb 2019
Consolidated Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017 · Shareholder (13 companies)
29 Jan 2019
Capital: €11M
5 Dec 2018 via BioNTech Real Estate Holding GmbH also 04/12/2018
Profit Transfer: AptaIT GmbH
31 Oct 2018
Patent: Peptide Mimotopes of Claudin 18.2 and Uses Thereof
18 Oct 2018
Capital: €10.7M · Company statute
4 Oct 2018
List of board members
12 Sept 2018
Capital: €10.6M
10 Sept 2018
Member of the Executive Board: Özlem Türeci
3 Jul 2018
Patent: Verfahren zur Bestimmung der Funktion von Nukleinsäuresequenzen und den dadurch kodierten Expressionsprodukten
5 Jun 2018
Consolidated Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016 · Shareholdings (11 companies)
28 Feb 2018
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016 · Shareholdings (11 companies)
21 Feb 2018
Patent: Identification of tumor-associated antigens for diagnosis and therapy
7 Feb 2018
Consolidated Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · Shareholdings (8 companies)
6 Feb 2018
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · Shareholder (10 companies)
1 Feb 2018
Entry lfd No. 12, column 6 b) of 14.09.2017 with correction of the date repeated: The Board of Directors is replaced by …
1 Feb 2018
Capital: €9,264,660 · Company statute
10 Jan 2018
Patent: Novel Substituted Imidazoquinolines
28 Dec 2017
Patent: Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
Year 2017 in Epobase
8 European patent filings: Particles Comprising Single Stranded RNA and Double Stranded RNA for Immunomodulation …
14 Sept 2017
Capital: €9,264,660 · Company statute
14 Sept 2017
Company statute
12 Sept 2017
Company statute
11 Sept 2017 via MIG GmbH & Co. Fonds 8 KG
Shareholder: MIG GmbH & Co. Fonds 8 KG
1 Feb 2017 in France
Address · Legal form: Société étrangère non immatriculée au RCS · Name: BIONTECH AG · Segment clas­si­fi­ca­tion
27 Jan 2017
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · Shareholdings (8 companies)
26 Jan 2017
Consolidated Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · Shareholdings (8 companies)
Year 2016 in Epobase
8 European patent filings: Identification of Tumour-Associated Cell Surface Antigens for Diagnosis and Therapy …
8 Nov 2016
Consolidated Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · Shareholder (10 companies)
28 Oct 2016
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · Shareholder (10 companies)
1 Jul 2016
Consolidated Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014 · Shareholdings (8 companies)
13 Apr 2016
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Shareholdings (8 companies)
Year 2015 in Dpmap
13 patent filings: Partikel mit Protamin und RNA in Kombination mit Endosomdestabilisierenden Mitteln …
Year 2015 in Epobase
15 European patent filings: Identification of Tumor-Associated Cell-Surface Antigens for Diagnosis and Theapy …
24 Jun 2015
Member of the Executive Board: Ugur Sahin · No longer Member of the Executive Board (1)
15 Jun 2015
Consolidated Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013 · Shareholder (10 companies)
24 Mar 2015
Capital: €181,660
5 Mar 2015
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Shareholdings (8 companies)
Year 2014 in Dpmam
5 trademark filings: MICROBODY, Microkine, Selecore …
7 Nov 2014
Member of the Executive Board: Sierk Poetting
Year 2014 in Epobase
8 European patent filings: Vaccine Composition Comprising 5'-CAP Modified RNA …
14 May 2014
Beteiligung
13 Mar 2014
Address
5 Mar 2014
Address
9 Jan 2014
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Shareholdings (6 companies)
Year 2013 in Epobase
9 European patent filings: Method and Kit for Determining Whether a Subject Shows an Immune Response …
Year 2013 in Dpmap
9 patent filings: Homo- und Heterodimere Mimetische Smac-Verbindungen ALS Apoptoseinduktoren …
1 Jun 2013 in Fts
EU funding: Merit
1 Jun 2013 in Fts
EU funding: Merit
20 Mar 2013
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Shareholdings (5 companies)
18 Dec 2012
Member of the Executive Board: Sean Marett
Year 2012 in Epobase
6 European patent filings: Recombinant Vaccines and USE Thereof …
1 Nov 2012 in Fts
EU funding (€1,143,277): Gapvac 305061
7 Sept 2012 in Fts
EU funding (€105,366): Initial Training Network for Neurogical Disorders Orchestrated by Cytokines
3 May 2012
Patent: Verfahren zur Bestimmung der Funktion von Nukleinsäuresequenzen und den dadurch kodierten Expressionsprodukten
2 Feb 2012
Patent: Verfahren zur Bestimmung der Funktion von Nukleinsäuresequenzen und den dadurch kodierten Expressionsprodukten
27 Sept 2011
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Shareholdings (5 companies)
24 May 2011
Patent: Individualized Vaccines for Cancer
27 Apr 2011
Patent: Selective, Local Activation of Members of the TNF Ligand Family of Systemically Inactive NON-Antibody TNF Ligand Fusion Proteins
2 Feb 2011
Patent: Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
Year 2010 in Dpmap
5 patent filings: Identifizierung von tumorassoziierten Zelloberflächen-Antigenen für die Diagnose und Therapie …
3 Dec 2010
Patent: Method for Cellular RNA Expression
23 Aug 2010
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009 · Shareholder (6 companies)
Year 2010 in Dpmam
7 trademark filings: BIONTECH, MICROBODY, Microkine, Selecore …
4 Aug 2010
Address
4 Aug 2010
Capital: €169,036 · Company statute
27 Jul 2010
Address · Capital: €169,036 · Company statute
9 Jun 2010
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008
16 Mar 2010
Patent: Tumor Vaccination Involving a Humoral Immune Response Against Self-Proteins
15 Mar 2010
Member of the Executive Board (1)
5 Jan 2010 via BioNTech Innovative Manufacturing Services GmbH also 18/09/2009
Control, Profit Transfer: Europäisches Institut für Forschung und Entwicklung von Transplantationsstrategien GmbH
5 Jan 2010 via BioNTech Diagnostics GmbH also 19/08/2009
Control, Profit Transfer: Theracode GmbH
5 Jan 2010 via BioNTech Cell & Gene Therapies GmbH also 19/08/2009
Control, Profit Transfer: UniCell GmbH
5 Jan 2010 via BioNTech RNA Pharmaceuticals GmbH also 19/08/2009
Control, Profit Transfer: Ribological GmbH
5 Jan 2010 via BioNTech Delivery Technologies GmbH also 08/09/2009
Control, Profit Transfer: Tulip GmbH
30 Oct 2009
Patent: Clonal Expansion of B Cells
5 Aug 2009
Patent: Vaccine Composition Comprising 5'-Cap Modified RNA
17 Jun 2009
Patent: Verfahren zur Diagnose von Krebsmetastasierung
9 Mar 2009
Member of the Executive Board: Ugur Sahin · Change of headquarters: BioNTech AG · Address · Share­holder agreement
2 Mar 2009
Change of headquarters: BioNTech AG
16 Feb 2009
Reg­is­tra­tion · CxO: Ugur Sahin · Change of headquarters: BioNTech AG · Address · Capital: €74,637 · Share­holder agreement · Legal form: AG · Name: BioNTech AG · Corporate Purpose
29 Dec 2008
Company statute
15 Dec 2008
Member of the Executive Board: Ugur Sahin · No longer Member of the Executive Board (1) · Address · Capital: €74,637 · Name: BioNTech AG · Company statute · Corporate Purpose
12 Dec 2008
Patent: Use of RNA for Reprogramming Somatic Cells
3 Nov 2008 as Petersberg 91. V V AG
Member of the Executive Board (1) · No longer Member of the Executive Board (1) · List of board members
22 Oct 2008
Patent: Identification of Tumor-Associated Markers for Diagnosis and Therapy
16 Jun 2008 as Petersberg 91. V V AG
Reg­is­tra­tion · Member of the Executive Board (1) · Capital: €50,000 · Proxy policy · Corporate Purpose
18 Feb 2008
Patent: Polypeptide Comprising a Knottin Protein Moiety
14 Dec 2007
Patent: Use of RNA for Reprogramming Somatic Cells
There are no publications matching your search.

Mentions

14 Feb 2026 in Rne
Reg­is­tra­tion: 01/02/2017 · Segment clas­si­fi­ca­tion · Corporate Purpose
28 Mar 2024 in Hrcdd
Profit Transfer: BioNTech Real Estate Holding GmbH
14 Feb 2020 in Hrdk
BioNTech Delivery Technologies GmbH: “Liste der Gesellschafter“
8 Aug 2018 in Hrdk also 11/04/2012
BioNTech Real Estate Holding GmbH: “Liste der Gesellschafter“
22 May 2017 in Hrdk
BioNTech Manufacturing GmbH: “Liste der Gesellschafter“
11 May 2015 in Hrdk
BioNTech Cell & Gene Therapies GmbH: “Liste der Gesellschafter“
Year 2009 in Hrcdd
Change of headquarters · Control (5 companies) · Profit Transfer (5 companies)
Year 2009 in Hrdk
Shareholdings (5 companies)
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.